Antipsychotic medication use by Medicaid recipients with severe mental illness

Bentson H. McFarland, T. Scott Stroup, Aileen B. Rothbard, Mary Rose Murrin, Paul G. Stiles, David L. Shern, Roger A. Boothroyd, Elizabeth I. Merwin, Joseph P. Morrissey

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Data on Medicaid recipients with severe mental illness were studied to determine antipsychotic medication use and any trends in racial variation in the prescribing of newer antipsychotic drugs. The study was conducted in 3 states. Participants were interviewed at entry into the study and again 6 months later. Interview data were linked with Medicaid eligibility information and claims data that included pharmacy records. Antipsychotic drugs, not infrequently in combination, are often prescribed for Medicaid recipients with severe mental illness. Medication use patterns tended to persist over the study period. No racial disparity with regard to use of newer antipsychotic medications was found. Further work is needed to understand psychotropic medication use by Medicaid recipients and to facilitate conformance with best-practice guidelines for treatment of persons with severe mental illness.

Original languageEnglish (US)
Pages (from-to)204-224
Number of pages21
JournalDrug Benefit Trends
Issue number4
StatePublished - Apr 2004
Externally publishedYes


  • Antipsychotic medications
  • Medicaid
  • Polypharmacy
  • Prescribing, race disparity

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)


Dive into the research topics of 'Antipsychotic medication use by Medicaid recipients with severe mental illness'. Together they form a unique fingerprint.

Cite this